Collagen Matrix Acquires Sunstar’s Degradable Solutions Product Line

Collagen Matrix, a developer of xenograft-derived tissue and bone repair/regeneration products and portfolio company of private equity firm Linden Capital, announced that it has acquired Sunstar’s Switzerland-based Degradable Solutions Division. The deal adds the GUIDOR® branded line of resorbable synthetic medical implants, which includes bone graft substitutes and bioresorbable matrix barrier membranes for dental surgical and restoration procedures.  The Degradable Solutions Division also recently developed a novel electrospinning technology, which produced a new non-woven, synthetic, electrospun dental membrane, which is CE marked and will launch in 2021.  Terms not announced.

Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare Mergers, Medical Implants